FOLR2 and cancer: Upregulation of FRβ on myeloid immune cells in cancer canserve as an advantage for targeting immunotherapy drugs into the tumormicroenvironment.12 Reprogramming the immunosuppressivecells for gaining antitumor capacities is a promising therapy approachin cancer.